Table 1.

Selected characteristics of ovarian cancer patients by survival status (n = 207)

Selected characteristicsAlive (n = 113), n (%)Dead (n = 94), n (%)
Age at diagnosis (y), mean (SD)*46.7 (12.7)51.6 (8.8)
    <4034 (30.1)7 (7.4)
    40-4933 (29.2)39 (41.5)
    50-5927 (23.9)29 (30.9)
    ≥6019 (16.8)19 (20.2)
Body height (cm), mean (SD)158.2 (4.9)158.1 (5.1)
Body weight (kg), mean (SD)
    At diagnosis55.5 (7.9)56.9 (8.7)
    5 y ago*54.8 (7.8)58.2 (7.7)
    At age 21 y51.7 (6.6)53.3 (6.4)
Body mass index (kg/m2), mean (SD)
    At diagnosis22.2 (2.9)22.7 (3.1)
    5 y ago*21.9 (2.7)23.3 (2.7)
    At age 21 y20.7 (2.4)21.3 (2.3)
Tobacco smoking
    Never111 (98.2)92 (97.9)
    Ever2 (1.8)2 (2.1)
Alcohol consumption
    Never79 (69.9)58 (61.7)
    Ever34 (30.1)36 (38.3)
Menopausal status
    Premenopause74 (65.5)50 (53.2)
    Postmenopause39 (34.5)44 (46.8)
Hormone replacement therapy
    Never110 (97.3)93 (98.9)
    Ever3 (2.7)1 (1.1)
Oral contraceptive use
    Never88 (77.9)72 (76.6)
    Ever25 (22.1)22 (23.4)
Ovarian cancer in first-degree relatives
    No110 (97.3)91 (96.8)
    Yes3 (2.7)3 (3.2)
Fesddration Internationale des Gynaecologistes et Obstetristes stage*
    I62 (54.9)3 (3.2)
    II14 (12.4)1 (1.1)
    III35 (30.9)78 (82.9)
    IV2 (1.8)12 (12.8)
Histopathologic grade*
    Well differentiated43 (38.1)4 (4.2)
    Moderately differentiated16 (14.2)20 (21.3)
    Poorly differentiated30 (26.5)61 (64.9)
    Not available24 (21.2)9 (9.6)
Ascites*
    No53 (46.9)2 (2.1)
    Yes60 (53.1)92 (97.9)
Residual lesions* (cm)
    <2100 (88.5)22 (23.4)
    ≥213 (11.5)72 (76.6)
Chemotherapy
    No3 (2.7)4 (4.3)
    Yes110 (97.3)90 (95.7)
  • NOTE: Differences between alive and dead patients were assessed using a χ2 test for categorical variables and a t test for continuous variables.

  • * P < 0.01.

  • P < 0.05.